These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


288 related items for PubMed ID: 15357740

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratory.
    Mader R, Ziporen L, Mader R, Neumann L, Buskila D.
    Clin Rheumatol; 2002 Sep; 21(5):386-90. PubMed ID: 12223987
    [Abstract] [Full Text] [Related]

  • 25. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS).
    Bidot CJ, Jy W, Horstman LL, Ahn ER, Yaniz M, Ahn YS.
    Am J Hematol; 2006 Jun; 81(6):391-6. PubMed ID: 16680753
    [Abstract] [Full Text] [Related]

  • 26. Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome.
    Sipek-Dolnicar A, Hojnik M, Rozman B, Vizjak A, Ferluga D.
    Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):707-10. PubMed ID: 11020961
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
    Marie I, Jouen F, Hellot MF, Levesque H.
    Br J Dermatol; 2008 Jan 25; 158(1):141-4. PubMed ID: 18028496
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Antiphospholipid antibodies syndrome in dermatology in Dakar: 11 case report].
    Diallo M, Niang SO, Kane A, Dieng MT, Ndiaye B.
    Dakar Med; 2007 Jan 25; 52(1):41-5. PubMed ID: 19102091
    [Abstract] [Full Text] [Related]

  • 34. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases.
    Francès C, Niang S, Laffitte E, Pelletier Fl, Costedoat N, Piette JC.
    Arthritis Rheum; 2005 Jun 25; 52(6):1785-93. PubMed ID: 15934071
    [Abstract] [Full Text] [Related]

  • 35. [Laboratory diagnosis of lupus anticoagulant].
    Swadźba J, Musiał J, Jankowski M, Bednarczyk M, Dyczek A, Szczeklik A.
    Pol Merkur Lekarski; 1996 Nov 25; 1(5):359-62. PubMed ID: 9273219
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Antiphospholipid antibodies in asymptomatic pediatric patients].
    Aguilar Franco C, Lucía Cuesta J.
    An Esp Pediatr; 2001 May 25; 54(5):444-9. PubMed ID: 11333473
    [Abstract] [Full Text] [Related]

  • 38. Laboratory tests for the antiphospholipid syndrome: current concepts.
    Passam F, Krilis S.
    Pathology; 2004 Apr 25; 36(2):129-38. PubMed ID: 15203748
    [Abstract] [Full Text] [Related]

  • 39. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov 25; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 40. Antiphospholipid and thrombosis syndromes.
    Bick RL, Baker WF.
    Semin Thromb Hemost; 1994 Nov 25; 20(1):3-15. PubMed ID: 8059232
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.